NCT01384058
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Brain Damage, Chronic, +21 more
- Locations
-
- Institut für Stoffwechselforschung Frankfurt, Germany
- Stephan Jacob, MD Villingen-Schwenningen, Germany
Clinical trial condition
Explore clinical trials studying Arterial Occlusive Diseases. Study availability and eligibility vary by location and protocol.
NCT01384058
NCT00919958
NCT01595776
NCT00560209
NCT00843102
NCT00311038
NCT00924586
NCT01419652
NCT01617031
NCT00642551